Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Concordia buys Amdipharm for $3.5bn in up-front and earn-out payments

Executive Summary

Concordia Healthcare Corp. acquired private specialty pharmaco Amdipharm Mercury Ltd. (AMCo) for $3.5bn: $1.2bn in cash, 8.5mm Concordia shares (valued at $643mm), the assumption of $1.4bn in AMCo debt, and a $220mm cash earn-out based on performance and due in Q4 2016.

Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Includes Earnout
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies